IL15 and leukemia: Our group and others have successfully expanded active PB NK cells or CB NK cells in vitro by co-culture with irradiated EBV-LCL, or with K562 cells expressing transfected cell-membrane bound IL-15 and 4-1BBL to kill leukemia and B-NHL [74–77].